<DOC>
	<DOCNO>NCT00358813</DOCNO>
	<brief_summary>The purpose study evaluate subject mild moderate kidney problem process breakdown study drug GW679769 body compare healthy subject .</brief_summary>
	<brief_title>Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<criteria>Inclusion criterion : Healthy mild moderate renal impairment . Females must nonchildbearing potential ( hysterectomy , bilateral oophorectomy , postmenopausal ) OR childbearing must negative pregnancy test meet/comply one following : abstinence , doublebarrier contraception , vasectomized partner ) . Be negative Hepatitis B C. Have negative result drug , alcohol HIV test . Have stable renal function . Exclusion criterion : Have peptic ulcer . Abuse drug alcohol . Are pregnant lactating . Have heart failure . Have uncontrolled emesis . Have infection . Have take received inducer inhibitor CYP3A4 CYP3A5 within 14 day study start . Active peptic ulcer disease . Digoxin use . Laboratory result show low iron pepsinogen level , AST CK level &gt; 1,5 ULN , show stool positive occult blood .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>emesis</keyword>
	<keyword>renal impairment</keyword>
	<keyword>GW679769</keyword>
	<keyword>kidney problem</keyword>
</DOC>